iRay Technology Hits Day High with 7.17% Surge, Outperforming Market

iRay Technology Co., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 7.17% on May 28, 2026. The stock reached an intraday high of CNY 210.58, showcasing its strong performance relative to the broader market. Over the past week, iRay Technology has demonstrated a remarkable 19.63% increase, and its one-month performance stands at an impressive 82.48%. In the context of the China Shanghai Composite, which only saw a modest gain of 0.12% on the same day, iRay Technology's performance highlights its market strength. Year-to-date, the stock has surged by 103.51%, significantly outpacing the composite index's 3.27% growth. Despite recent gains, the company has faced challenges, including negative results in the last three consecutive quarters and a decline in profits over the past year. Nevertheless, iRay Technology's current market capitalization stands at CNY 28,291 million, reflecting its large-cap status in the industry. With a price-to-earnings ratio of 37.00 and a return on equity of 10.61%, the company continues to navigate a competitive landscape.